asa guidelines for glp 1 agonists Anesthetic Considerations Patients Taking Glucagon-Like Peptide-1 Perioperative Use of GLP-1 Receptor

Metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus: a review and position statement of the fatty liver research group of the Korean Diabetes Association

Implications for Patient Care and Provider Guidance The study serves as a wake-up call for healthcare providers to engage in ongoing conversations with patients about medication benefits, potential side effects, and adherence

Percentage of Mounjaro Users Experiencing Vision Changes The use of a GLP-1 drug is associated with a fourfold higher risk of NAION when used to treat type 2 diabetes

These milestones highlight the growing regulatory and clinical momentum supporting expanded uses Ongoing trials are also exploring the impact of GLP-1 agonists on cardiovascular outcomes, liver health, and even neurodegenerative diseases, reinforcing their value in treating systemic metabolic disorders

These injections are designed to mimic the actions of the naturally occurring GLP-1 hormone, which plays a crucial role in regulating insulin secretion, glucose homeostasis, and appetite

Chemically similar to fructose, allulose provides approximately 70% of the sweetness of sucrose while contributing less than 10% of its caloric content